Heart Failure

The second volume in this series reviews another year in which more advances have been made and further insights gained into this challenging disease. Leading authorities bring their own expertise to this series of reviews, each of which addresses a topic on which clinicians need an up-to-date assessment of our current knowledge.Recent research into basic mechanisms of disease is evaluated, together with the interrelationships with comorbidities such as anaemia and diabetes. New diagnostic and monitoring procedures are discussed, with an update on the role of natriuretic peptides, genomics and monitoring devices. The latest developments in therapy are reviewed with reference to recent trials, with special chapters on acute decompensated heart failure, the role of stains and other drug therapies, as well as LVAD therapies and the use of support devices.The volume concludes with an update on current recommendations for best practice, with special emphasis on broader issues of disease management, including risk profiling and care of special patient groups with pre-existing disease, in particular the elderly.
It includes updates on recent trials and new drug therapies, and discusses latest best practice guidelines. It assesses recent advances in understanding basic disease mechanisms. It evaluates new monitoring and support devices.